Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
13.13
+0.08 (0.61%)
Nov 20, 2024, 4:00 PM EST - Market closed
Viatris Revenue
Viatris had revenue of $3.75B in the quarter ending September 30, 2024, a decrease of -4.84%. This brings the company's revenue in the last twelve months to $15.05B, down -2.70% year-over-year. In the year 2023, Viatris had annual revenue of $15.43B, down -5.14%.
Revenue (ttm)
$15.05B
Revenue Growth
-2.70%
P/S Ratio
1.04
Revenue / Employee
$396,013
Employees
38,000
Market Cap
15.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
Dec 31, 2019 | 11.50B | 66.60M | 0.58% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 37.54B |
Tenet Healthcare | 20.97B |
Baxter International | 15.06B |
Quest Diagnostics | 9.54B |
ICON Public Limited Company | 8.31B |
Moderna | 5.08B |
Incyte | 4.08B |
Align Technology | 3.96B |
VTRS News
- 5 days ago - Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript) - Seeking Alpha
- 12 days ago - Bargain Priced Viatris Reports Strong Q3 Earnings Results - Seeking Alpha
- 13 days ago - Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown - Benzinga
- 13 days ago - Viatris Inc. (VTRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Xanax maker Viatris beats quarterly estimates on demand for new generic drugs - Reuters
- 14 days ago - Viatris Reports Third Quarter Financial Results for 2024 - PRNewsWire
- 16 days ago - Viatris Announces Third Quarter 2024 Dividend - PRNewsWire
- 22 days ago - Viatris Named to Forbes' World's Top Companies for Women 2024 List - PRNewsWire